Challenges With the Use of JAK Inhibitors

Key Takeaways

• Patient selection is critical, as response to oral JAK inhibitors varies among individuals with alopecia.
• Monitoring for side effects, including infection risk and blood count changes, is essential for safe use.
• Limited long-term safety data necessitates cautious use and further research into oral JAK inhibitors.
• Cost and insurance coverage challenges can hinder patient access to these treatments.